A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

June 27, 2024

Study Completion Date

June 27, 2024

Conditions
COVID-19
Interventions
DRUG

PF-07817883

Experimental

Trial Locations (6)

33024

Research Centers of America ( Hollywood ), Hollywood

Research Centers of America, Hollywood

33603

Genesis Clinical Research, LLC, Tampa

91763

Catalina Research Institute, LLC, Montclair

92801

Anaheim Clinical Trials, LLC, Anaheim

92844

National Institute of Clinical Research, Garden Grove

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY